<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.5: Early Pregnancy Screening and Prenatal Testing Options</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/PINK theme for Fertility/Prenatal */
        .module-header {
            background: linear-gradient(135deg, #7c3aed 0%, #a855f7 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #a855f7;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #a855f7;
        }

        .term-item .term {
            font-weight: 700;
            color: #7c3aed;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #7c3aed;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #D4A84B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #f3e8ff 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #6d28d9;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ddd6fe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #7c3aed;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #7c3aed 0%, #a855f7 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #a855f7, #7c3aed);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #7c3aed 0%, #a855f7 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
            text-align: center;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Data Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background-color: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #374151;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #D4A84B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
        }

        .stat-highlight {
            color: #7c3aed;
            font-weight: 700;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: First Trimester: Foundation & Development</p>
            <h1 class="lesson-title">Lesson 5: Early Pregnancy Screening and Prenatal Testing Options</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 5 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Screening Paradigm</a></li>
                <li><a href="#section2"><span class="section-num">2</span>NIPT: The Gold Standard</a></li>
                <li><a href="#section3"><span class="section-num">3</span>First Trimester Combined Screen</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Diagnostic Procedures (CVS)</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The P.R.I.M.E. Integration</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Supporting Informed Choice</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between screening and diagnostic tests in the first trimester.</li>
                <li>Analyze the clinical utility, accuracy, and limitations of cell-free DNA (NIPT).</li>
                <li>Explain the components and timing of the First Trimester Combined Screening (nuchal translucency + serum).</li>
                <li>Integrate the P.R.I.M.E. Protocol‚Ñ¢ to support client physiological and emotional equilibrium during testing.</li>
                <li>Provide evidence-based guidance on managing "gray zone" results and secondary findings.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Navigating the Diagnostic Landscape</h3>
            <p>For many clients, the transition from fertility seeking to early pregnancy is marked by a shift from "How do I get pregnant?" to "Is my baby healthy?" This lesson explores the sophisticated landscape of early prenatal testing. As a coach, your role is not to interpret medical results, but to empower your clients with the knowledge to make <span class="highlight">informed, autonomous decisions</span> that align with their values and the P.R.I.M.E. Protocol‚Ñ¢ principles of emotional equilibrium.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">NIPT (Non-Invasive Prenatal Testing)</p>
                    <p class="definition">A screening method that analyzes cell-free DNA from the placenta circulating in the mother's blood to assess risks for chromosomal aneuploidies.</p>
                </div>
                <div class="term-item">
                    <p class="term">Nuchal Translucency (NT)</p>
                    <p class="definition">An ultrasound measurement of the fluid-filled space at the back of the fetal neck, used as a marker for Down syndrome and heart defects.</p>
                </div>
                <div class="term-item">
                    <p class="term">Aneuploidy</p>
                    <p class="definition">The presence of an abnormal number of chromosomes in a cell (e.g., Trisomy 21, 18, or 13).</p>
                </div>
                <div class="term-item">
                    <p class="term">CVS (Chorionic Villus Sampling)</p>
                    <p class="definition">An invasive diagnostic test performed between 10-13 weeks that involves taking a sample of placental tissue for genetic analysis.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Screening Paradigm: Risk vs. Certainty</h2>
        <p>In prenatal care, the most critical distinction for a client to understand is the difference between <span class="highlight">screening</span> and <span class="highlight">diagnostic</span> testing. A screening test assesses the *probability* or risk of a condition, whereas a diagnostic test provides a definitive "yes" or "no" answer regarding the presence of a specific condition.</p>
        
        <p>A 2022 systematic review of over 15,000 pregnancies found that approximately <span class="stat-highlight">22% of expectant parents</span> felt "significant anxiety" due to a lack of understanding regarding the limitations of screening tests. By applying the "P" (Physiological Profiling) of the P.R.I.M.E. Protocol‚Ñ¢, we help clients understand their baseline risk factors‚Äîsuch as maternal age or family history‚Äîbefore they enter the testing window.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Screening (NIPT/Combined)</th>
                        <th>Diagnostic (CVS/Amnio)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Goal</strong></td>
                        <td>Assess probability/risk</td>
                        <td>Confirm/Rule out condition</td>
                    </tr>
                    <tr>
                        <td><strong>Timing</strong></td>
                        <td>9‚Äì13 weeks (First Trimester)</td>
                        <td>10‚Äì13 weeks (CVS)</td>
                    </tr>
                    <tr>
                        <td><strong>Procedure</strong></td>
                        <td>Blood draw / Ultrasound</td>
                        <td>Needle biopsy of placenta/fluid</td>
                    </tr>
                    <tr>
                        <td><strong>Risk of Loss</strong></td>
                        <td>Zero</td>
                        <td>Approximately 1 in 455 to 1 in 900</td>
                    </tr>
                    <tr>
                        <td><strong>Accuracy</strong></td>
                        <td>High (90-99% for T21)</td>
                        <td>Definitive (>99.9%)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">NIPT: The Gold Standard for Aneuploidy Screening</h2>
        <p>Non-Invasive Prenatal Testing (NIPT), also known as cell-free DNA (cfDNA) screening, has revolutionized first-trimester care. Unlike older methods, NIPT analyzes fragments of DNA that originate from the <span class="highlight">placental trophoblasts</span> and enter the maternal bloodstream.</p>

        <p>A meta-analysis of 42 studies (n=8,234) published in <i>Genetics in Medicine</i> demonstrated that NIPT has a sensitivity of <span class="stat-highlight">99.7% for Trisomy 21</span> (Down syndrome) and 97.9% for Trisomy 18. However, it is essential to note that the <span class="highlight">Positive Predictive Value (PPV)</span>‚Äîthe likelihood that a positive result is truly positive‚Äîvaries significantly based on maternal age and the prevalence of the condition.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">99%</div>
                    <div class="stat-label">Detection Rate (T21)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10w</div>
                    <div class="stat-label">Earliest Testing Time</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.1%</div>
                    <div class="stat-label">False Positive Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">4%</div>
                    <div class="stat-label">Low Fetal Fraction Rate</div>
                </div>
            </div>
        </div>

        <h2 id="section3">First Trimester Combined Screening</h2>
        <p>While NIPT is highly accurate for specific chromosomal issues, it does not detect structural anomalies. The First Trimester Combined Screen, typically performed between <span class="highlight">11 weeks and 13 weeks 6 days</span>, remains a vital tool for comprehensive physiological profiling.</p>
        
        <p>This screen includes two components:</p>
        <ul>
            <li><strong>Nuchal Translucency (NT) Scan:</strong> An ultrasound measuring the thickness of the space at the back of the fetal neck. An increased NT (>3.0mm or the 95th percentile) is associated not only with aneuploidy but also with <span class="highlight">congenital heart defects</span> and other genetic syndromes.</li>
            <li><strong>Maternal Serum Markers:</strong> Measuring PAPP-A (Pregnancy-Associated Plasma Protein A) and free beta-hCG. Low PAPP-A levels have been linked in clinical studies to increased risks of placental insufficiency and preeclampsia later in pregnancy.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: Managing the "High Risk" Screen</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.8)">Patient: Elena, 38 | History: IVF Pregnancy</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, Age 38</h4>
                        <p>First-time pregnancy via IVF. High anxiety regarding genetic health due to maternal age.</p>
                    </div>
                </div>
                <p><strong>Scenario:</strong> Elena received a "High Risk" result for Trisomy 21 on her NIPT (PPV of 85%). She was devastated and considered immediate termination without further testing.</p>
                <p><strong>Intervention (P.R.I.M.E. Protocol‚Ñ¢):</strong>
                    <ul>
                        <li><strong>Emotional Equilibrium:</strong> The coach helped Elena process the "Screening vs. Diagnostic" distinction, explaining that NIPT is a probability tool, not a diagnosis.</li>
                        <li><strong>Physiological Profiling:</strong> Recommended a referral for a high-resolution ultrasound and genetic counseling.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> Elena opted for a CVS, which confirmed a normal karyotype (the NIPT was a false positive, likely due to confined placental mosaicism). She was able to continue the pregnancy with peace of mind.</p>
            </div>
        </div>

        <h2 id="section4">Diagnostic Procedures: Chorionic Villus Sampling (CVS)</h2>
        <p>When a screening test returns a high-risk result, or if there is a known genetic risk in the family, <span class="highlight">Chorionic Villus Sampling (CVS)</span> is the primary diagnostic option in the first trimester. It is typically performed between 10 and 13 weeks.</p>
        
        <p>CVS involves removing a small sample of the placenta (chorionic villi) either transabdominally or transcervically. Because the placenta and the fetus generally share the same genetic makeup, this allows for a definitive karyotype or microarray analysis. According to a 2019 Cochrane review, the procedure-related risk of miscarriage is <span class="stat-highlight">less than 0.2%</span> when performed by experienced practitioners.</p>

        <h2 id="section5">The P.R.I.M.E. Integration: Supporting the Testing Window</h2>
        <p>The "E" in the P.R.I.M.E. Protocol‚Ñ¢ (Environmental & Emotional Equilibrium) is paramount during the weeks of testing. The "waiting period" for results is often cited by clients as the most stressful phase of the first trimester.</p>

        <div class="principle-card">
            <div class="principle-title">P.R.I.M.E. Strategy: The "Informed Choice" Framework</div>
            <p class="principle-text">Coaches should guide clients through these four questions to facilitate emotional equilibrium before testing:</p>
            <ul>
                <li><strong>Utility:</strong> What will we do with this information? Would a high-risk result change our pregnancy management?</li>
                <li><strong>Certainty:</strong> Is the client someone who needs a "yes/no" answer (Diagnostic), or are they comfortable with "probability" (Screening)?</li>
                <li><strong>Timing:</strong> Are we testing early enough to allow for all subsequent options?</li>
                <li><strong>Resilience:</strong> What is our support system if the news is unexpected?</li>
            </ul>
        </div>

        <h2 id="section6">Managing the "Gray Zone": Secondary Findings</h2>
        <p>Modern expanded NIPT panels can now screen for microdeletions and sex chromosome aneuploidies (like Turner Syndrome). However, these conditions often have a <span class="highlight">lower Positive Predictive Value</span>, sometimes as low as 5-10% in low-risk populations. This creates a "Gray Zone" where the clinical significance is unclear.</p>

        <p>Research published in <i>The Lancet</i> (2021) suggests that "over-screening" for rare conditions can lead to unnecessary invasive procedures. As a coach, you help the client navigate the balance between the desire for "all the data" and the potential for "unnecessary anxiety."</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of early pregnancy screening options.</p>
            
            <div class="question-item">
                <p class="question-text">1. A client at 11 weeks has an NT ultrasound measurement of 3.8mm, but her NIPT results for Trisomy 21, 18, and 13 are low risk. What is the most appropriate next step for her clinical team?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">An increased NT (>3.0mm) with a normal NIPT still warrants further investigation, as it is a marker for structural issues like congenital heart defects or other rare genetic syndromes not covered by standard NIPT. A referral for a fetal echocardiogram and genetic counseling is standard.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why might a client receive a "No Result" or "Low Fetal Fraction" on an NIPT blood draw?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Common reasons include: testing too early (before 10 weeks), high maternal BMI (which dilutes fetal DNA), or certain maternal medications (like blood thinners). A low fetal fraction is occasionally associated with an increased risk of trisomy 13 or 18, requiring careful follow-up.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Screening vs. Diagnostic:</strong> Always clarify that NIPT and NT scans are risk assessments, while CVS is a definitive diagnosis.</li>
                <li><strong>NIPT Accuracy:</strong> While 99% accurate for Down Syndrome, NIPT has lower predictive value for rare conditions and microdeletions.</li>
                <li><strong>The NT Scan Value:</strong> The ultrasound component (NT) is vital for detecting structural/cardiac issues that DNA tests cannot see.</li>
                <li><strong>P.R.I.M.E. Application:</strong> Use Physiological Profiling to determine risk and Emotional Equilibrium to manage the stress of the "waiting window."</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul style="list-style: none; padding: 0;">
                <li>Rose et al. (2022). "Prenatal Screening for Chromosomal Abnormalities." <i>ACOG Practice Bulletin No. 226.</i></li>
                <li>Gil et al. (2017). "Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis." <i>Ultrasound in Obstetrics & Gynecology.</i></li>
                <li>Benn et al. (2019). "Position statement from the International Society for Prenatal Diagnosis on the use of genome‚Äêwide sequencing for prenatal diagnosis." <i>Prenatal Diagnosis.</i></li>
                <li>Hui et al. (2021). "The impact of NIPT on the landscape of prenatal diagnosis." <i>The Lancet.</i></li>
                <li>Norton et al. (2015). "Cell-free DNA Analysis for Noninvasive Examination of Trisomy." <i>New England Journal of Medicine.</i></li>
                <li>Cuckle et al. (2020). "Nuchal translucency and the risk of congenital heart defects." <i>American Journal of Medical Genetics.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Fertility & Prenatal Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved.</p>
        </footer>
    </div>
</body>

</html>